Search

Your search keyword '"Brendan C. Lanpher"' showing total 77 results

Search Constraints

Start Over You searched for: Author "Brendan C. Lanpher" Remove constraint Author: "Brendan C. Lanpher"
77 results on '"Brendan C. Lanpher"'

Search Results

1. Bi-allelic variants in CELSR3 are implicated in central nervous system and urinary tract anomalies

2. Pediatric manifestations of Lynch Syndrome: A single center experience

3. Bilateral subdural hematomas and retinal hemorrhages mimicking nonaccidental trauma in a patient with D‐2‐hydroxyglutaric aciduria

4. Expanding the clinical and phenotypic heterogeneity associated with biallelic variants in ACO2

5. The prevalence of diseases caused by lysosome-related genes in a cohort of undiagnosed patients

6. Expansion of the Genotypic and Phenotypic Spectrum of WASF1-Related Neurodevelopmental Disorder

8. Neonatal Diagnosis of Alveolar Capillary Dysplasia via Rapid Genomic Sequencing: A New Gold Standard?

9. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

10. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

11. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

12. De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy

13. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

15. <scp>TSPEAR</scp>variants are primarily associated with ectodermal dysplasia and tooth agenesis but not hearing loss: A novel cohort study

16. A form of muscular dystrophy associated with pathogenic variants in JAG2

17. Bilateral subdural hematomas and retinal hemorrhages mimicking nonaccidental trauma in a patient with D‐2‐hydroxyglutaric aciduria

18. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

19. One is the loneliest number: genotypic matchmaking using the electronic health record

20. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

21. Growth hormone deficiency in a child with <scp>branchio‐oto‐renal</scp> spectrum disorder: Clinical evidence of <scp> EYA1 </scp> in pituitary development and a recommendation for pituitary function surveillance

22. Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder

23. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

24. Impact of integrated translational research on clinical exome sequencing

25. Left-sided valvular heart disease and retinopathy in a 38-year-old woman with attenuated mucopolysaccharidosis: a case report

26. Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome

27. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

28. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification

29. Kabuki syndrome: international consensus diagnostic criteria

30. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

31. iDe novo/icoding variants in theiAGO1/igene cause a neurodevelopmental disorder with intellectual disability

32. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

33. Clinical utility of genomic sequencing: a measurement toolkit

34. Pathogenic SPTBN1 variants cause a novel autosomal dominant neurodevelopmental syndrome

35. Novel loss-of-function variants in TRIO are associated with neurodevelopmental disorder: case report

36. Expanding the clinical and phenotypic heterogeneity associated with biallelic variants in ACO2

37. A novel missense variant and multiexon deletion causing a delayed presentation of xeroderma pigmentosum, group C

38. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor beta Signaling

39. Deficient histone H3 propionylation by BRPF1-KAT6 complexes in neurodevelopmental disorders and cancer

40. Refinement of the clinical and mutational spectrum of UBE2A deficiency syndrome

42. The prevalence of diseases caused by lysosome-related genes in a cohort of undiagnosed patients

43. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

44. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

45. Expansion of the Genotypic and Phenotypic Spectrum of WASF1-Related Neurodevelopmental Disorder

46. Clinical and genetic characterization of AP4B1 ‐associated SPG47

47. Spectrum of Hematological Malignancies in 130 Patients with Germline Predisposition Syndromes - Mayo Clinic Germline Predisposition Study

48. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Callosum, Axon, Cardiac, Ocular, and Genital Defects

49. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

50. Complex phenotypes in ALG12-congenital disorder of glycosylation (ALG12-CDG): Case series and review of the literature

Catalog

Books, media, physical & digital resources